Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Robbins

Showing results (181-190 of 274) with videos related to

Pageof 28
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effectsS C Ghivizzani, E R Lechman, R Kang, et al.
Annals of the Rheumatic Diseases|April 30, 2005
Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in miceP Mukherjee, S-Y Yang, B Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyW Hashimoto, T Osaki, H Okamura, et al.
Gene Therapy|September 1, 1995
Complementation of defective leucine decarboxylation in fibroblasts from a maple syrup urine disease patient by retrovirus-mediated gene transferG M Mueller, L R McKenzie, G E Homanics, et al.
Gene Therapy|November 1, 1995
Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNAS S Boggs, K D Patrene, G M Mueller, et al.
The Journal of Surgical Research|February 1, 1995
Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapyI Pappo, H Tahara, P D Robbins, et al.
Pathology|October 1, 1994
Stereotactic biopsy of 100 intracerebral lesions at Sir Charles Gairdner HospitalP D Robbins, L L Yu, M Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998
Retroviral expression of MUC-1 human tumor antigen with intact repeat structure and capacity to elicit immunity in vivoR A Henderson, W M Konitsky, S M Barratt-Boyes, et al.
Gene Therapy|February 15, 2001
Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitopeA Gambotto, G Dworacki, V Cicinnati, et al.
Gene Therapy|May 19, 2006
Direct adenovirus-mediated IGF-I gene transduction of synovium induces persisting synovial fluid IGF-I ligand elevationsL R Goodrich, B D Brower-Toland, L Warnick, et al.
Pageof 28

Showing results (181-190 of 274) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effectsS C Ghivizzani, E R Lechman, R Kang, et al.
Annals of the Rheumatic Diseases|April 30, 2005
Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in miceP Mukherjee, S-Y Yang, B Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyW Hashimoto, T Osaki, H Okamura, et al.
Gene Therapy|September 1, 1995
Complementation of defective leucine decarboxylation in fibroblasts from a maple syrup urine disease patient by retrovirus-mediated gene transferG M Mueller, L R McKenzie, G E Homanics, et al.
Gene Therapy|November 1, 1995
Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNAS S Boggs, K D Patrene, G M Mueller, et al.
The Journal of Surgical Research|February 1, 1995
Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapyI Pappo, H Tahara, P D Robbins, et al.
Pathology|October 1, 1994
Stereotactic biopsy of 100 intracerebral lesions at Sir Charles Gairdner HospitalP D Robbins, L L Yu, M Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998
Retroviral expression of MUC-1 human tumor antigen with intact repeat structure and capacity to elicit immunity in vivoR A Henderson, W M Konitsky, S M Barratt-Boyes, et al.
Gene Therapy|February 15, 2001
Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitopeA Gambotto, G Dworacki, V Cicinnati, et al.
Gene Therapy|May 19, 2006
Direct adenovirus-mediated IGF-I gene transduction of synovium induces persisting synovial fluid IGF-I ligand elevationsL R Goodrich, B D Brower-Toland, L Warnick, et al.
Pageof 28